Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
A non-inferiority randomized control trial in treatment naïve HIV patients to compare
virologic effect of two backbone regimens with Epzicom (lamivudine and abacavir) and Truvada
(emtricitabine and tenofovir). Both arms are treated with fixed combination of ritonavir
boosted atazanavir as key drugs.